In this article we will talk about some macroeconomic data from the country, as well as some data from the pharmaceutical market.

In the next articles, we will go deeper into our analysis talking about patents, distribution, private label, among other subjects.

With this, we hope to demonstrate Brazil's real potential for healthcare markets.

Population: 214 million

GDP: 2.249 trillion reais (R$) in the first quarter of 2022.

Exchange rate: 1 U$ = 5.32 BRL (value on 07/04/2022)

Health Expenses: 1,300 U$/per inhabitant/per year (includes public and private expenses).

Total Pharmaceutical Market: 7.1 billion units/MAT ABR 22. In revenue, R$ 158.7 billion/MAT ABR 22.

Breakdown by product type: 92.9 billion in the retail market and 65.8 billion in the non-retail market.

Public institutions demanded 36.2 billion reais in this period

The largest companies in the retail market are national. Among the top 10, five are multinationals, in positions 4, 7, 8, 9 and 10.

In the non-retail market, there are four multinational companies among the top ten, in positions 5, 6, 7 and 9.

If you need a timely review, please write to us and we will be happy to respond to you.